| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-10 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0007 |